Science Corporation · The Techno Optimist

Analyst view

Main trial (NEJM, Oct 2025): about 80% of patients saw meaningfully better after 12 months; many could read letters and words.
EU approval (CE mark) in Jul 2026 allows sales in 30 European countries; first paid implants expected in Germany.
Raised $230M in Mar 2026 to launch PRIMA and fund its brain-interface research.

As reported

Chip

A 2 x 2 mm chip, thinner than a hair, with 378 pixels turns flashes of infrared light into electrical current; no battery or wires.

Glasses

Glasses film the scene and beam it onto the chip as infrared light, which the remaining eye can't see, so natural side vision is kept.

Biology

In this disease the light-sensing cells die but the next layer survives; the chip stimulates it and the eye passes the signal to the brain.

Programs

Science Corporation, one program

Updated 22 Jul 2026

Research · Proto · Pilot · Deploy · Scaling

1 item

Open · Active · Partial

Blurry pictureActive research
Its 100-micron pixels limit sharpness to well below normal vision; smaller pixels need new designs.
Surgery and trainingPartially solved
Placing the chip under the retina is delicate, and patients need months of training to use the new vision.

1 round · as reported

Date	Round	Amount	Post-money	Lead
Mar 2026	Series C	$230M	—	—

1 supplier · 1 partner

Supplier
Pixium Vision (opens science.xyz)
Science acquired the PRIMA assets from Pixium in 2024.
Partner
Stanford University (opens stanford.edu)
PRIMA's photovoltaic design originated in Daniel Palanker's lab.

Key people